Banco BTG Pactual’s Antares Pharma, Inc. ATRS Stock Holding History

Banco BTG Pactual’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-11,298	Closed	-$37K	–	79
2017 Q3	$37K	Buy	+11,298	New	+$34.9K	0.02%	72

Other funds holding ATRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Banco BTG Pactual's ATRS Position: Q4 2017 in Review

Banco BTG Pactual sold out of Antares Pharma, Inc. (ATRS) in Q4 2017, closing a stake of 11,298 shares — an estimated $37K sold.

Banco BTG Pactual first reported a position in ATRS in Q3 2017 and held it in 1 quarter. The position peaked at $37K in Q3 2017. 110 funds tracked by Wall St. Rank hold ATRS as of Q4 2017.

Banco BTG Pactual reported no remaining Antares Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Banco BTG Pactual sold 11,298 Antares Pharma, Inc. shares in Q4 2017, an estimated $37K.
Banco BTG Pactual first reported a position in Antares Pharma, Inc. in Q3 2017 and held it in 1 quarter.
Banco BTG Pactual's Antares Pharma, Inc. position peaked at $37K in Q3 2017.
110 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2017.

Based on Banco BTG Pactual's 13F filing for Q4 2017, filed 9 Feb 2018.